Sealer-Based Obturation With AH Plus Bioceramic Sealer vs. Warm Vertical Compaction With AH Plus
Outcome of Sealer-Based Obturation With AH Plus Bioceramic Sealer Versus Warm Vertical Compaction With AH Plus: A CBCT-Based Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Calcium silicate sealers are used in endodontics because of their biocompatibility, bioactivity, and their ability to form a hydroxyapatite-mediated interfacial bond with root canal dentine. Although in vitro and retrospective clinical studies have reported promising findings, there remains a lack of prospective, well-controlled trials evaluating their clinical and radiographic performance.
Aims and Objectives:
- To compare the clinical outcome of single-cone bioceramic obturation (SBO) with warm vertical compaction (WVC) in primary root canal treatment.
- To compare the radiographic outcome of SBO and WVC using periapical (PA) radiographs and cone-beam computed tomography (CBCT).
Materials and Methods:
Patients referred for primary root canal treatment of molar teeth at Jaber Al-Ahmed Dental Center who fulfil the inclusion and exclusion criteria will be invited to participate. Written informed consent will be obtained from all participants.
Preoperative PA radiographs and CBCT scans will be taken. After completion of root canal instrumentation, participants will be randomly allocated to either Group A: SBO or Group B: WVC. Participants will be blinded to the obturation technique. Allocation will remain concealed until canals are ready for obturation, at which time the treating clinician will be informed of the assigned method.
All teeth will receive definitive restorations following obturation. Participants will be recalled at 12-24 months for clinical and radiographic evaluation using PA radiographs and CBCT, and will subsequently be followed annually for up to 5 years.
The study will conform to the CONSORT statement and will be conducted in accordance with the Declaration of Helsinki. Ethical approval has been granted by the local health authority (ID: 2291).
Statistical and Analytical Plan:
The sample size was determined for a non-inferiority comparison of the primary success proportion between the treatment group (AH Plus Bioceramic Sealer) and the reference group. Assuming a reference-group success proportion of 92%, a non-inferiority margin of 13 percentage points (δ₀ = -0.13), and no true difference between groups under the alternative hypothesis (δ₁ = 0), a one-sided, two-sample Z-test with unpooled variance at a significance level of 0.05 required 54 evaluable participants per group (108 in total) to achieve 80% power. To account for an anticipated attrition rate of 30%, the enrollment target was inflated to 78 participants per group (156 in total), applying the formula N' = N / (1 - 0.30). All calculations were performed using PASS (NCSS, LLC, Kaysville, UT, USA).
Healing at 12-24 months will serve as the dependent variable in logistic regression models. Predictor variables will include age, sex, preoperative status, presence of apical periodontitis, preoperative pain, patency, apical preparation size, root filling quality, and sealer type. Two-way interactions will be assessed. Analyses will follow the intention-to-treat principle.
Null Hypothesis:
H₀: There is no difference between SBO and WVC in clinical or radiographic healing outcomes at 12-24 months.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hawalli Governate
-
Janūb as Surrah, Hawalli Governate, Kuwait, 00000
- Jaber Al-Ahmed Dental Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants must be 18-65 years of age at the time of recruitment
- Participants must have a classification of I or II on the American Society of Anesthesiologists (ASA) physical status classification system
- Participants must not have known allergies to any materials used in the study
- Participants must agree to participate in the study by signing a consent form
- Participants must have good oral hygiene
- Maxillary and mandibular permanent molar teeth that require primary root canal treatment will be included
- The teeth must be restorable and have fully formed roots with no advanced periodontal disease
Exclusion Criteria:
- ASA classification of III or more
- Pregnant or breastfeeding women
- Patients who are unable to give consent
- Patients who have advanced periodontal disease or teeth with more than 5mm probing
- Anterior, premolar and third molar teeth
- Teeth whose apices were over-enlarged at the time of pulp extirpation
- Teeth with broken instruments
- Teeth with blocked or non-negotiable canals
- Teeth with iatrogenic perforations
- Teeth with incomplete root formation
- Teeth with internal or external root resorption
- Teeth that have a poor restorative prognosis
- Teeth that require posts or extensive prosthetic rehabilitation
- Teeth with cracks
- Teeth that have been previously root-filled
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SBO with AH Plus Bioceramic Sealer
The teeth will be obturated using a single cone technique with AH Plus Bioceramic Sealer.
|
A bioactive, calcium silicate-based sealer will be used in combination with the core root canal filling material (gutta-percha).
It's premixed and is dispensed in the root canal via a fine disposable syringe.
|
|
Active Comparator: WVC with resin-based AH Plus Sealer
The teeth will be obturated using warm vertical compaction with resin-based AH Plus Sealer.
|
A resin-based sealer will be used in combination with the core root canal material (gutta-percha).
It consists of two pastes that are mixed together in equal amounts prior to application.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of radiographic healing with cone beam computed tomography (CBCT) scans using Estrela's PAI (periapical index)
Time Frame: Change from baseline periapical lesion size at 12-24 months
|
Estrela's PAI based on CBCT will be used in logistic regression models with different predictor variables.
|
Change from baseline periapical lesion size at 12-24 months
|
|
Assessment of clinical outcome by assessing the resolution/persistence/development of clinical signs and symptoms
Time Frame: Change from baseline at 12-24 months
|
The examiner will label the teeth as having a normal clinical outcome (absence of pain, swelling and other symptoms, no sinus tract, no loss of function) or showing signs and symptoms clinical outcome (the tooth is associated with signs and/or symptoms of infection).
|
Change from baseline at 12-24 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2291
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.